Junyu Xu
Beijing, 100190, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The SIK3-N783Y mutation is associated with the human natural short sleep trait.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 05, 2025
Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Clinical pharmacology in drug development
Published: November 07, 2024
Safety and Pharmacokinetics of Single-Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study.
Journal: Clinical pharmacology in drug development
Published: March 26, 2024
Physiologically-based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co-administered with ritonavir.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 07, 2024
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers.
Journal: Clinical drug investigation
Published: May 29, 2023
Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: April 16, 2023
Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study.
Journal: Advances in therapy
Published: June 24, 2021
Safety, Efficacy, Pharmacokinetic and Pharmacodynamic evaluation of YF-H-2015005 for mobilizing Hematopoietic stem cells in Non-Hodgkin's Lymphoma Patients.
Journal: Journal of Cancer
Published: May 27, 2020
Photodetection and Safety of 5-Aminolevulinic Acid-Induced Porphyrin in Patients With Cervical Intraepithelial Neoplasia.
Journal: Lasers in surgery and medicine
Published: May 10, 2020
A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: August 19, 2019
Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients.
Journal: Current drug metabolism
Published: March 12, 2019
The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations.
Journal: Asian journal of pharmaceutical sciences
Published: February 27, 2019
Last Updated: 09/26/2026